TET2 and myelodysplastic syndrome: As loss-of-function mutations in the TET2 gene are among the most common drivers of human preleukemia,47,48,49 this analysis not only provides complementary results to the original publication but also serves to demonstrate the broad utility of our PMCA pipeline for streamlined characterization of mutational effects.